The present study evinces MMP7, MMP10 and MMP12 level in a homogenous collective of colon cancer patients ́ sera to have predictive significance and boosts the idea that these markers represent essential prognostic factors and are probable molecular targets for tailored, individualized therapeutic approaches for prospective antitumoral strategies. The gene discussed is MMP12; the disease is colonic neoplasm.